Biopharmaceutical Analysis

Latest News


Why Automation with the Correct Liquid Handler is Integral to Improved NGS Outcomes

NGS abbreviates drug discovery timelines.

Why Automation with the Correct Liquid Handler is Integral to Improved NGS Outcomes

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

Navigating Challenges in Cell Therapy Potency Assays

Developing cell-based potency assays for cell therapies requires meticulous coordination.

Navigating Challenges in Cell Therapy Potency Assays

Laura_Bush_rev-512655-1408655766019.jpg

In the context of process validation, the confirmation of a belief must be checked repeatedly, throughout the product lifecycle.

Tab1_Min_approach_vs_QbD-513383-1408654962604.gif

The principles of QbD can be applied to biotech development and manufacturing to help resolve many common issues. QbD scientifically provides a greater understanding of the complex relationships among product quality attributes, the manufacturing process, and clinical safety and efficacy by determining the various permutations of critical input variables that will keep the product within specification.

i4-490815-1408653010390.jpg

Formal Method Validation

The development and optimization process can improve a method, but validation does not. Validation is the final proof that regulations and expectations are met.

i4-490817-1408653006090.jpg

Several steps can be taken to maintain test method suitability after the formal completion of the analytical method validation studies,

i4-416132-1416913854938.jpg

A tremendous amount of analytical testing is required to support a biopharmaceutical product from discovery, development, and clinical trials, through manufacturing and marketing. Numerous methods are used to fully characterize large molecules because of their complexity-characterizing them is significantly more difficult than it is for small molecules. Biopharmaceuticals are produced via living systems, i.e., E. coli, yeast, or mammalian cells, which require additional testing matrices.